BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
4 hedge funds and large institutions have $335K invested in Biostar Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Acadian Asset Management
Boston,
Massachusetts
|
$331K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$3K |
| 3 |
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1K |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Acadian Asset Management
Boston,
Massachusetts
| $331K | 101,195 | +85,628 | +550% |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | 986 | +672 | +214% |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | 400 | +399 | +39,900% |
|
|
VF
4
Virtu Financial
New York
| – | – | -14,186 | Closed |
|
5
Morgan Stanley
New York
| $0 | 24 | – | – |
|